
Dolby Laboratories (DLB) Stock Forecast & Price Target
Dolby Laboratories (DLB) Analyst Ratings
Bulls say
Dolby Laboratories is set to continue its growth trajectory in the coming years, with the recent retirement of CEO Kevin Yeaman and the appointment of Marc Whitten as the new CEO. Whitten's background in product development is a clear signal of the company's focus on expanding its technology offerings beyond just audio. Despite potential challenges in the supply chain and the need to convince device manufacturers to adopt new technologies, Dolby's dominant market position, strong cash flow, and expanding adoption of Atmos and Vision in various devices provide a strong foundation for growth. The stock is currently trading at a P/E of 13.5x on CY27 EPS, and we maintain a Buy rating on the stock with a target price of $85, reflecting a 19x multiple on CY26 EPS which reflects the company's strong financials and market position.
Bears say
Dolby Laboratories is experiencing a negative outlook due to its dependence on device licensing for revenue, with its new revenue sources from VDP and OptiView still in their early stages. While management is successfully driving growth in Atmos and Vision, a general uptick in end demand is needed to excite investors. Its solid market position, strong cash flow, and growing base of licensed devices could support future growth, but current risks and uncertainties have led to a stagnant stock price.
This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.
Dolby Laboratories (DLB) Analyst Forecast & Price Prediction
Start investing in Dolby Laboratories (DLB)
Order type
Buy in
Order amount
Est. shares
0 shares